Splenic Artery Aneurysm: An Endovascular Approach to Therapy
- Volume 4 - Issue 5 - Sept/Oct 2007
- Posted on: 9/5/08
- 2 Comments
- 43824 reads
Yuri Pride, MD, Benjamin Rester, MD, Lawrence Garcia, MD
Aneurysms of the splenic artery are the third most common intra-abdominal aneurysms, with aneurysms of the aorta and iliac arteries being most and second most common, respectively.1 However, splenic artery aneurysms (SAAs), with an incidence as high as 10% in certain series, are the most common visceral artery aneurysms.2 The detection of SAAs is likely rising in the setting of increasing frequency of advanced abdominal imaging.3 The most commonly cited risk factors for SAAs are portal hypertension and multiple pregnancies.1,4 Presentation varies from benign, incidental findings on abdominal imaging studies to hypovolemic shock secondary to aneurysmal rupture. The incidence of aneurysm rupture has been reported to occur in about 5% of cases at presentation.5
Because they are relatively rare, the optimal treatment of SAAs is unknown; there are no guidelines as to which aneurysms should be treated with what modalities. Traditionally, surgery has been considered the best invasive management strategy. However, with the advent of advanced endovascular techniques and growing interest from interventionalists, the approach to management is changing. Here, we present a case of an incidentally found SAA, describe its treatment with endovascular coil embolization, and review the literature on SAAs and their management.
A 71-year-old man with hypertension, glucose intolerance, hyperlipidemia, aortic stenosis, and peripheral arterial occlusive disease presented to an outside hospital with sudden onset nausea, vomiting, and abdominal pain, eventually presumed to be secondary to viral gastroenteritis. During his hospital stay, he underwent computed tomography (CT) of the abdomen. While there was no bowel pathology, note was made of a calcified 2.8 x 2.5 cm SAA, with no evidence of surrounding hematoma. He was referred for endovascular management of his SAA.
A 5-Fr sheath was inserted in the right femoral artery via the modified Seldinger technique. Angiography was performed, revealing a large splenic artery aneurysm > 2.5 cm in size. Through a 7-Fr Arrow sheath (Arrow International, Reading, Pennsylvania), the vessel was engaged with an angled soft glidewire (Boston Scientific, Natick, Massachusetts), which was then positioned near the aneurysmal sac. A glide catheter (Boston Scientific) was advanced into the sac, and four Nestor coils (Cook UK Ltd, Letchworth, United Kingdom), measuring 12 mm x 14 cm, were deployed into the aneurysm. Stent implantation into the neck of the aneurysm could not be performed due to vessel tortuosity and severe angulation of the neck. Final angiography revealed continued flow in the splenic artery and decreased flow in the aneurysmal sac. The procedure was well tolerated, and there were no immediate complications.
Follow-up CT of the patient’s abdomen two months later revealed no obvious opacification of the aneurysm sac, with IV contrast and normal perfusion of the splenic parenchyma.
Splenic artery aneurysms are the third most common intra-abdominal arterial aneurysm and the most common visceral artery aneurysm.1,2 Autopsy studies have revealed an incidence of 0.1% in the general population, as high as 10% in those over 60 years of age and up to 50% in those with portal hypertension.6 Risk factors for splenic aneurysm include portal hypertension, systemic hypertension, multiparity, arterial fibrodysplasia, chronic inflammatory processes, and arteriosclerosis.7
Most patients are asymptomatic and present after aneurysms are incidentally discovered on abdominal imaging. Symptoms that have been attributed to SAAs include left upper quadrant pain, nausea, and vomiting. The most ominous presentation is hypovolemic shock secondary to aneurysmal rupture. This occurs in approximately 3–10% of cases,8 more often, after liver transplantation, and carries with it a 10–25% risk of mortality among nonpregnant patients, and up to a 70% risk of mortality in pregnant women.7,9
Because of the relative rarity of SAAs, indications for intervention are not standardized. It has been suggested that aneurysms in pregnant women, women of childbearing age, patients with symptoms possibly related to their aneurysm, and those undergoing liver transplantation should undergo repair.10 Other groups have recommended repairing asymptomatic aneurysms based on their size, with initial cutoffs starting at 1.5 cm.5
Therapeutic options for the treatment of SAAs include open or laparoscopic surgical repair or endovascular repair with coil embolization, stent graft implantation, or glue embolization. Rupture is most often treated with emergent open surgical repair, although there are case reports of percutaneous coil embolization in the acute setting.11 The strategies most often implemented in patients presenting for elective repair are laparoscopic surgery, which is limited by technical constraints or endovascular coil embolization.
Traditional surgical techniques have been associated with a high degree of morbidity, including splenectomy (about 25%) and distal pancreatectomy (about 10%), and mortality (5% in elective cases and up to 40% in emergent cases).5,7
1. Stanley JC, Thompson NW, Fry WJ. Splanchnic artery aneurysms. Arch Surg 1970;101:689–697.
2. Messina LM, Shanley CJ. Visceral artery aneurysms. Surg Clin North Am 1997;77:425–442.
3. Saltzberg SS, Maldonado TS, Lamparello PJ, et al. Is endovascular therapy the preferred treatment for all visceral artery aneurysms? Ann Vasc Surg 2005;19:507–515.
4. Holdsworth RJ, Gunn A. Ruptured splenic artery aneurysm in pregnancy. A review. Br J Obstet Gynaecol 1992;99:595–597.
5. Abbas MA, Stone WM, Fowl RJ, et al. Splenic artery aneurysms: Two decades experience at Mayo Clinic. Ann Vasc Surg 2002;16:442–449.
6. Ayalon A, Wiesner RH, Perkins JD, et al. Splenic artery aneurysms in liver transplant patients. Transplantation 1988;45:386–389.
7. Lee PC, Rhee RY, Gordon RY, et al. Management of splenic artery aneurysms: The significance of portal and essential hypertension. J Am Coll Surg 1999;189:483–490.
8. Shih A, Golden M, Mohler ER 3rd. Splenic artery aneurysm. Vasc Med 2002;7:155–156.
9. Guillon R, Garcier JM, Abergel A, et al. Management of splenic artery aneurysms and false aneurysms with endovascular treatment in 12 patients. Cardiovasc Intervent Radiol 2003;26:256–260.
10. Dave SP, Reis ED, Hossain A, et al. Splenic artery aneurysm in the 1990s. Ann Vasc Surg 2000;14:223–229.
11. Kim BS, Do HM, Razavi M. N-butyl cyanoacrylate glue embolization of splenic artery aneurysms. J Vasc Interv Radiol 2004;15:91–94.
12. Probst P, Castaneda-Zuniga WR, Gomes AS, et al. Nonsurgical treatment of splenic artery aneurysms. Radiology 1978;128:619–623.
13. McDermott VG, Shlansky-Goldberg R, Cope C. Endovascular management of splenic artery aneurysms and pseudoaneurysms. Cardiovasc Intervent Radiol 1994;17:179–184.
14. Brountzos EN, Vagenas K, Apostolopoulou SC, et al. Pancreatitis-associated splenic artery pseudoaneurysm: Endovascular treatment with self-expandable stent-grafts. Cardiovasc Intervent Radiol 2003;26:88–91.